Research Analysts Set Expectations for BCAX Q2 Earnings
Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) – Research analysts at Wedbush cut their Q2 2025 EPS estimates for shares of Bicara Therapeutics in a note issued to investors on Tuesday, May 13th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.45) for the quarter, down from their […]
Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) – Research analysts at Wedbush cut their Q2 2025 EPS estimates for shares of Bicara Therapeutics in a note issued to investors on Tuesday, May 13th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.45) for the quarter, down from their […]
